{"id":"https://openalex.org/W88323562","doi":null,"title":"[The effect of second generation histamine antagonists on the heart].","display_name":"[The effect of second generation histamine antagonists on the heart].","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W88323562","mag":"88323562","pmid":"https://pubmed.ncbi.nlm.nih.gov/11575008"},"language":"pl","primary_location":{"id":"pmid:11575008","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11575008","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumonologia i alergologia polska","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071968284","display_name":"I Grzelewska-Rzymowska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"I Grzelewska-Rzymowska","raw_affiliation_strings":["Kliniki Gru\u017alicy i Chor\u00f3b P\u0142uc IMW Akademii Medycznej w \u0141odzi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kliniki Gru\u017alicy i Chor\u00f3b P\u0142uc IMW Akademii Medycznej w \u0141odzi","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069304532","display_name":"Magdalena Pietrzkowicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Pietrzkowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054601941","display_name":"Marta G\u00f3rska","orcid":"https://orcid.org/0000-0001-6926-1717","observed_orcids":["https://orcid.org/0000-0001-6926-1717","https://orcid.org/0000-0002-2194-6263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M G\u00f3rska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00983049,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"69","issue":"3-4","first_page":"217","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/second-generation-antihistamines","display_name":"second-generation antihistamines","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cardiac-effects","display_name":"cardiac effects","score":0.628000020980835},{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":0.8149999976158142},{"id":"https://openalex.org/keywords/astemizole","display_name":"astemizole","score":1.0},{"id":"https://openalex.org/keywords/loratadine","display_name":"loratadine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/ebastine","display_name":"ebastine","score":0.871999979019165},{"id":"https://openalex.org/keywords/cetirizine","display_name":"cetirizine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/fexofenadine","display_name":"fexofenadine","score":0.984000027179718},{"id":"https://openalex.org/keywords/potassium-channel-blockade","display_name":"potassium channel blockade","score":0.6909999847412109},{"id":"https://openalex.org/keywords/herg-channel","display_name":"hERG","score":0.8399999737739563},{"id":"https://openalex.org/keywords/kv1-5","display_name":"Kv1.5","score":0.9089999794960022},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/arrhythmogenic-effects","display_name":"arrhythmogenic effects","score":0.6370000243186951},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2776129107","wikidata":"https://www.wikidata.org/wiki/Q423437","display_name":"Astemizole","level":2,"score":0.9602166414260864},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.9587525129318237},{"id":"https://openalex.org/C2780734495","wikidata":"https://www.wikidata.org/wiki/Q424049","display_name":"Loratadine","level":2,"score":0.9495498538017273},{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.914344072341919},{"id":"https://openalex.org/C2776711289","wikidata":"https://www.wikidata.org/wiki/Q415122","display_name":"Fexofenadine","level":2,"score":0.7781452536582947},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7020493149757385},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6788889169692993},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.5791575312614441},{"id":"https://openalex.org/C2780486423","wikidata":"https://www.wikidata.org/wiki/Q1625433","display_name":"Torsades de pointes","level":3,"score":0.5155282020568848},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.4909108281135559},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4828105866909027},{"id":"https://openalex.org/C2778457506","wikidata":"https://www.wikidata.org/wiki/Q7234689","display_name":"Potassium channel blocker","level":3,"score":0.44637593626976013},{"id":"https://openalex.org/C2779463773","wikidata":"https://www.wikidata.org/wiki/Q423075","display_name":"Cetirizine","level":2,"score":0.4113496243953705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33926087617874146}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002090","descriptor_name":"Butyrophenones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013610","descriptor_name":"Tachycardia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016589","descriptor_name":"Astemizole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016593","descriptor_name":"Terfenadine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017336","descriptor_name":"Loratadine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11575008","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11575008","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumonologia i alergologia polska","raw_type":"English Abstract"},{"id":"mag:88323562","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11575008","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2150391039","https://openalex.org/W2100764569","https://openalex.org/W1901270449","https://openalex.org/W2087738977","https://openalex.org/W2025043418","https://openalex.org/W2885456345","https://openalex.org/W2033999167","https://openalex.org/W1982613279","https://openalex.org/W2069980076","https://openalex.org/W10330520"],"abstract_inverted_index":{"The":[0,166,187],"review":[1],"summarizes":[2],"recent":[3],"progress":[4],"in":[5,25,81,121],"the":[6,9,21,44,57,128,195],"study":[7],"of":[8,12,20,29,43,60,113,157,198,208],"cardiac":[10,67],"actions":[11],"second--generation":[13],"antihistamines.":[14],"Terfenadine":[15],"and":[16,46,55,78,97,132,143,177,184,194,203,212],"astemizole,":[17],"two":[18],"antihistamines":[19,190],"second":[22],"generation,":[23],"are":[24],"vitro":[26],"potent":[27],"blockers":[28],"potassium":[30,95,103],"channels":[31,120,138],"(K+).":[32],"It":[33],"has":[34],"been":[35],"considered":[36],"to":[37,92,124],"be":[38],"responsible":[39],"for":[40],"QT":[41,181,209],"prolongation":[42,183,211],"electrocardiogram":[45],"life--treating":[47],"ventricular":[48],"tachycardias":[49],"called":[50],"torsades":[51],"de":[52],"pointes.":[53],"Loratadine":[54],"descarboethoxyloratadine,":[56],"major":[58,155,196],"metabolite":[59,80,156,197],"loratadine":[61,88,148,193],"were":[62,206],"studied":[63],"on":[64,117],"a":[65],"human":[66,74,106],"K+":[68,119,137],"channel":[69,96],"(hKv":[70],"1.5)":[71],"cloned":[72,105],"from":[73],"ventricle.":[75],"Parent":[76],"compound":[77],"its":[79],"high":[82],"concentration":[83,122],"blocked":[84,135],"hKv1.5":[85],"channels.":[86],"However,":[87],"(10":[89],"mumol/L)":[90],"failed":[91],"inhibit":[93,102],"HERG":[94,98,118,136,163],"K+.":[99],"Ebastine":[100],"also":[101],"channels,":[104],"Kv":[107],"1.5.":[108],"Cetirizine":[109],"was":[110,149],"completely":[111],"devoid":[112,207],"any":[114],"inhibitory":[115],"action":[116],"up":[123],"30":[125],"mumd/L.":[126],"On":[127],"other":[129,188,213],"hand":[130],"terfenadine":[131,201],"astemizole":[133,176,204],"effectively":[134],"with":[139],"nanomolar":[140],"affinities":[141],"(330":[142],"480":[144],"nmol/L,":[145],"respectively),":[146],"whereas":[147],"about":[150],"300-fold":[151],"less":[152],"potent.":[153],"Fexofenadine--the":[154],"terfenadine,":[158,175],"does":[159],"not":[160],"block":[161],"either":[162],"or":[164],"Kv1.5.":[165],"quinea":[167],"pig":[168],"model":[169],"(in":[170],"vitro)":[171],"revealed":[172],"that":[173],"only":[174],"ebastine":[178,199],"produced":[179],"significant":[180],"interval":[182,210],"arrhythmogenic":[185],"effects.":[186,216],"nonsedating":[189],"including":[191],"cetirizine,":[192],"(carabastine),":[200],"(feksofenadine)":[202],"(norastemizole)":[205],"adverse":[214],"ECG":[215]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}